MedTrace Logo

RCT of Meditation and Health Education on CIMT and MACE in Black Women and Men

NCT05642936 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 197

Last updated 2025-05-30

No results posted yet for this study

Summary

This was a randomized, single-blind, controlled, community-based trial comparing the clinical efficacy of the Transcendental Meditation program on carotid intima-media thickness and major adverse cardiovascular events in 197 African American men and women at risk for atherosclerotic CVD. After baseline testing, participants were randomly assigned to either a stress reduction program (Transcendental Meditation) or a standard health education program. Follow up was conducted over one year and 12 years.

Conditions

Interventions

BEHAVIORAL

didactic health education control

didactic classroom-based comparison group that follows standard guidelines for diet, exercise and substance use with no stress reduction component

BEHAVIORAL

Transcendental Meditation technique

a mental technique derived from the Vedic tradition of ancient India and practiced by anyone for 20 minutes twice a day sitting

Sponsors & Collaborators

  • College of Medicine, Charles R. Drew University of Medicine and Science

    collaborator UNKNOWN

  • Barbara Streisand Women's' Heart Center, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California

    collaborator UNKNOWN

  • Maharishi International University

    lead OTHER

Principal Investigators

  • Robert H Schneider, M.D. · Maharishi International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-10-31
Primary Completion
2005-07-31
Completion
2014-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05642936 on ClinicalTrials.gov